IRadimed Corporation (IRMD)
NASDAQ: IRMD · IEX Real-Time Price · USD
41.86
+0.39 (0.94%)
Apr 26, 2024, 4:00 PM EDT - Market closed
IRadimed Market Cap
IRadimed has a market cap or net worth of $530.06 million as of April 26, 2024. Its market cap has increased by 1.45% in one year.
Market Cap
530.06M
Enterprise Value
482.35M
1-Year Change
1.45%
Ranking
Category
Stock Price
$41.86
Market Cap Chart
Since July 16, 2014, IRadimed's market cap has increased from $100.50M to $530.06M, an increase of 427.43%. That is a compound annual growth rate of 18.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 530.10M | 0.95% |
Apr 25, 2024 | 525.10M | -2.29% |
Apr 24, 2024 | 537.40M | 1.28% |
Apr 23, 2024 | 530.60M | -1.08% |
Apr 22, 2024 | 536.40M | 3.31% |
Apr 19, 2024 | 519.20M | 1.58% |
Apr 18, 2024 | 511.10M | -0.27% |
Apr 17, 2024 | 512.50M | -1.37% |
Apr 16, 2024 | 519.60M | 0.37% |
Apr 15, 2024 | 517.70M | -0.98% |
Apr 12, 2024 | 522.80M | -1.67% |
Apr 11, 2024 | 531.70M | 2.01% |
Apr 10, 2024 | 521.20M | -1.99% |
Apr 9, 2024 | 531.80M | -0.67% |
Apr 8, 2024 | 535.40M | -0.48% |
Apr 5, 2024 | 538.00M | 3.03% |
Apr 4, 2024 | 522.20M | -2.54% |
Apr 3, 2024 | 535.80M | -0.92% |
Apr 2, 2024 | 540.80M | -0.44% |
Apr 1, 2024 | 543.20M | -2.48% |
Mar 28, 2024 | 557.00M | 1.42% |
Mar 27, 2024 | 549.20M | 1.84% |
Mar 26, 2024 | 539.30M | -0.85% |
Mar 25, 2024 | 543.90M | -0.66% |
Mar 22, 2024 | 547.50M | -2.86% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ORIC Pharmaceuticals | 543.72M |
Phathom Pharmaceuticals | 536.82M |
Valneva SE | 531.55M |
InnovAge Holding | 531.37M |
Prime Medicine | 530.73M |
Talkspace | 526.98M |
OmniAb | 524.72M |
Calliditas Therapeutics AB (publ) | 523.32M |